Table 1 Patient characteristics of the study population and by multistate transition.
From: The natural history of symptomatic COVID-19 during the first wave in Catalonia
From general population | From diagnosed with COVID-19 | From hospitalised with COVID-19 | |||||
|---|---|---|---|---|---|---|---|
General population | To diagnosed with COVID-19 | To hospitalised with COVID-19 | To death | To hospitalised with COVID-19 | To death | To death | |
N | 5,586,521 | 102,002 | 8041 | 11,327 | 8860 | 2581 | 2692 |
Days since index date (median [IQR]) | 24 [19.0, 32.0] | 33 [27.0, 40.0] | 26 [21.0, 35.0] | ||||
Age (median [IQR]) | 43 [25.0, 60.0] | 46 [35.0, 58.0] | 71 [58.0, 80.0] | 85 [76.0, 90.0] | 60 [49.0, 73.0] | 86 [80.0, 91.0] | 80 [73.0, 86.0] |
Age gr (%) | |||||||
Under 18 | 966,680 (17.3) | 4536 (4.4) | 34 (0.4) | 9 (0.1) | 40 (0.5) | <5 | <5 |
18–39 | 1,437,297 (25.7) | 30,530 (29.9) | 426 (5.3) | 80 (0.7) | 850 (9.6) | 5 (0.2) | 11 (0.4) |
40–59 | 1,785,852 (32.0) | 44,493 (43.6) | 1776 (22.1) | 657 (5.8) | 3441 (38.8) | 63 (2.4) | 142 (5.3) |
60–69 | 615,538 (11.0) | 10,305 (10.1) | 1558 (19.4) | 1026 (9.1) | 1673 (18.9) | 131 (5.1) | 292 (10.8) |
70–79 | 468,662 (8.4) | 6120 (6.0) | 2162 (26.9) | 1967 (17.4) | 1602 (18.1) | 406 (15.7) | 822 (30.5) |
80 or older | 312,492 (5.6) | 6018 (5.9) | 2085 (25.9) | 7588 (67.0) | 1254 (14.2) | 1976 (76.6) | 1424 (52.9) |
Sex = female (%) | 2,831,062 (50.7) | 59,006 (57.8) | 3439 (42.8) | 5672 (50.1) | 3989 (45.0) | 1467 (56.8) | 1075 (39.9) |
Region (%) | |||||||
Barcelona | 4,169,520 (74.6) | 82,702 (81.1) | 7201 (89.6) | 8694 (76.8) | 7604 (85.8) | 2164 (83.8) | 2393 (88.9) |
Girona | 557,006 (10.0) | 9929 (9.7) | 432 (5.4) | 942 (8.3) | 657 (7.4) | 217 (8.4) | 158 (5.9) |
Lleida | 370,570 (6.6) | 5621 (5.5) | 211 (2.6) | 728 (6.4) | 391 (4.4) | 108 (4.2) | 94 (3.5) |
Tarragona | 489,378 (8.8) | 3748 (3.7) | 196 (2.4) | 958 (8.5) | 207 (2.3) | 92 (3.6) | 45 (1.7) |
Missing | 47 (0.0) | <5 | <5 | 5 (0.0) | <5 | <5 | <5 |
Charlson comorbidity index (%) | |||||||
0 | 4,558,137 (81.6) | 80,214 (78.6) | 3627 (45.1) | 1613 (14.2) | 5385 (60.8) | 365 (14.1) | 583 (21.7) |
1 | 400,005 (7.2) | 8996 (8.8) | 1036 (12.9) | 1607 (14.2) | 1031 (11.6) | 519 (20.1) | 427 (15.9) |
2 | 357,892 (6.4) | 6846 (6.7) | 1409 (17.5) | 2304 (20.3) | 1164 (13.1) | 460 (17.8) | 559 (20.8) |
3+ | 270,487 (4.8) | 5946 (5.8) | 1969 (24.5) | 5803 (51.2) | 1280 (14.4) | 1237 (47.9) | 1123 (41.7) |
Autoimmune condition (%) | 273,496 (4.9) | 6251 (6.1) | 806 (10.0) | 1285 (11.3) | 727 (8.2) | 275 (10.7) | 326 (12.1) |
Chronic kidney disease (%) | 202,102 (3.6) | 3934 (3.9) | 1408 (17.5) | 3710 (32.8) | 892 (10.1) | 887 (34.4) | 819 (30.4) |
COPD (%) | 119,950 (2.1) | 2359 (2.3) | 740 (9.2) | 1457 (12.9) | 463 (5.2) | 261 (10.1) | 363 (13.5) |
Dementia (%) | 42,579 (0.8) | 1933 (1.9) | 429 (5.3) | 2701 (23.8) | 294 (3.3) | 990 (38.4) | 376 (14.0) |
Heart disease (%) | 533,261 (9.5) | 10,732 (10.5) | 2611 (32.5) | 5686 (50.2) | 1903 (21.5) | 1175 (45.5) | 1324 (49.2) |
Hyperlipidemia (%) | 515,045 (9.2) | 10,820 (10.6) | 1498 (18.6) | 1580 (13.9) | 1507 (17.0) | 381 (14.8) | 508 (18.9) |
Hypertension (%) | 689,436 (12.3) | 13,747 (13.5) | 2405 (29.9) | 3834 (33.8) | 2206 (24.9) | 896 (34.7) | 932 (34.6) |
Malignant neoplasm (%) | 291,535 (5.2) | 5595 (5.5) | 1327 (16.5) | 3751 (33.1) | 991 (11.2) | 588 (22.8) | 670 (24.9) |
Obesity (%) | 928,163 (16.6) | 20,761 (20.4) | 3216 (40.0) | 3184 (28.1) | 3103 (35.0) | 695 (26.9) | 1088 (40.4) |
Type 2 diabetes (%) | 317,505 (5.7) | 6000 (5.9) | 1644 (20.4) | 2612 (23.1) | 1284 (14.5) | 590 (22.9) | 710 (26.4) |
